alexa Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
Surgery

Surgery

Medical & Surgical Urology

Author(s): Fujimoto K, Hamamoto Y, Honjo S, Kawasaki Y, Mori K,

Abstract Share this page

Abstract We retrospectively examined the frequency of bladder cancer in Japanese patients with type 2 diabetes in relation to use of pioglitazone. Among a total of 663 patients identified to be taking pioglitazone, 9 had bladder cancer (1.36\%). Overall the hazard ratio of 1.75 [95\% CI: 0.89-3.45] for pioglitazone for bladder cancer was not significant. However the prevalence of bladder cancer was 2.10\% in patients taking pioglitazone for less than 24 months which was significant increased (HR 2.73 [95\% CI: 1.11-6.72]). Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. This article was published in Diabetes Res Clin Pract and referenced in Medical & Surgical Urology

Relevant Expert PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords